Chemcon Speciality Chemicals Q1 FY27: Realizations lift margins as product mix stays organic-led

Q1 FY27 revenue from operations was 66.5 crore, EBITDA was 15.4 crore, and PAT was 11.0 crore as per the presentation.

EBITDA increased from 7.7 crore in Q1 FY26 to 15.4 crore in Q1 FY27, and PAT increased from 6.4 crore to 11.0 crore. EBITDA margin rose from 14.5% to 23.2%.

The company operates in Organic Chemicals and Inorganic Chemicals. Organic includes HMDS, CMIC, Bromobenzene and 2 Bromo, while Inorganic includes bromides such as calcium bromide, zinc bromide and sodium bromide.

In Q1 FY27, exports were 31% and domestic was 69%. In FY26, exports were 41% and domestic was 59% (export data includes deemed exports).

The company states it is the only manufacturer of HMDS in India and the third largest HMDS manufacturer worldwide, the largest CMIC manufacturer worldwide, the only manufacturer of zinc bromide in India, and the largest manufacturer of calcium bromide in India.

The presentation highlights capacity expansion via the upcoming P11 unit for organic chemicals, import substitution opportunities, exploring new applications and new products, and cost efficiency initiatives through process improvements and scale benefits.

Management notes pricing pressure from global competition, particularly imports from China in select products, and uncertainty from global macroeconomic conditions, geopolitical developments, and crude oil volatility.